[Retracted] Clinical Study of Sentinel Lymph Node Detection to Evaluate Pelvic Lymph Node Metastasis to Determine the Prognosis of Patients with Early Cervical Cancer

Table 5

Univariable analyses for DFS and OS.

Variables	5-years OS				5-years DFS
	Survival rates	HR	95%CI	P	Survival rates	HR	95%CI	P
Tumor diameter, mm
≦2cm	100	2.7	(1.163,6.269)	<0.05	100	2.149	(1.087,4.248)	<0.05
>2cm,≤4cm	92.7				90.4
>4cm	86.6				83.6
BMI(kg/m^2)
≦25	91.8	1.242	(0.561,2.750)	>0.05	89.9	1.292	(0.678,2.461)	>0.05
>25,≦30	89.5				87.4
>30	85.7				88.9
Histology
Squamous cell carcinoma	92.4	1.246	(0.544,2.856)	>0.05	89.5	1.289	(0.453,2.397)	>0.05
Adenocarcinoma	87.5			>0.05	87.5			>0.05
else	88.9				90.0
LNM
No	97.1	9.874	(3.478,28.032)	<0.001	94.5	4.209	(1.892,9.397)	<0.01
Yes	72.9				71.5
LVSI
No	93.4	3.223	(1.132,9.171)	<0.05	91.4	2.167	(0.803,5.848)	>0.05
Yes	77.6				72.6
FIGO Stage
Ia2	100	2.064	(1.203,3.540)	<0.01	100	1.471	(0.950,2.277)	<0.05
Ib1	94.9				91.7
Ib2	92.5			0.010	90.4			>0.05
IIa1	84.2				83.0
IIa2	82.4				81.8
Differentiation
Grade I	95.7	1.467	(0.735,2.927)	>0.05	95.8	1.801	(0.977,3.321)	0.05
Grade II	91.4				90.8
Grade III	90.4				86.8
Invasion Depth
≤1/3	92.4	1.551	(1,2.405)	0.050	91.5	1.289	(0.904,1.840)	>0.05
1/3-2/3	100				96.7
>2/3	94.8				93.5
whole cervix	77.6				72.8